| Long name: |
BBS7 Primary Polyclonal Antibody |
| Also known as: |
BBS7 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
BBS7 |
| Specificity: |
This is a highly specific antibody against BBS7 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human BBS7 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
BBS is a heterogeneous disorder mapping to eight genetic loci and encoding eight proteins, BBS patients also have an increased risk of developing diabetes, BBS1-BBS8, BBS2 contains two overlapping genes: BBS2L1 and BBS2L2, BBS7 contains 672 amino acids and is expressed at low to moderate levels in most human tissues, BBSL1 was re-named BBS7, Five BBS proteins encode basal body or cilia proteins, and congenital heart defects, and developmental delay, hypertension, hypogenitalism, photoreceptor degeneration, polydactyly, renal abnormalities, suggesting that BBS is a ciliary dysfunction disorder, whereas BBS2L2 independently funcitons as BBS1, Bardet-Biedl syndrome (BBS) is a pleiotropic genetic disorder characterized by obesity |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
BBS2-like 1, BBS7_HUMAN, Bardet-Biedl syndrome 7 protein, Bardet-Biedl syndrome 7 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
BBS7 |
| Short name: |
BBS7 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
Bardet-Biedl syndrome 7 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BBS7 and IDBG-36452 and ENSG00000138686 and 55212, BBS7 and IDBG-639728 and ENSBTAG00000004945 and 100138953, Bbs7 and IDBG-138825 and ENSMUSG00000037325 and 71492, nuclei, protein binding, this GO :0001103 and RNA polymerase II repressing transcription factor binding and molecular function this GO :0001654 and eye development and biological process this GO :0001947 and heart looping and biological process this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005813 and centrosome and cellular component this GO :0005930 and axoneme and cellular component this GO :0006357 and regulation of transcription from RNA polymerase II promoter and biological process this GO :0007224 and smoothened signaling pathway and biological process this GO :0007368 and determination of left/right symmetry and biological process this GO :0007420 and brain development and biological process this GO :0007507 and heart development and biological process this GO :0007601 and visual perception and biological process this GO :0008104 and protein localization and biological process this GO :0015031 and protein transport and biological process this GO :0032402 and melanosome transport and biological process this GO :0032436 and positive regulation of proteasomal ubiquitin-dependent protein catabolic process and biological process this GO :0034464 and BBSome and cellular component this GO :0035058 and nonmotile primary cilium assembly and biological process this GO :0036064 and ciliary basal body and cellular component this GO :0045444 and fat cell differentiation and biological process this GO :0048546 and digestive tract morphogenesis and biological process this GO :0051877 and pigment granule aggregation in cell center and biological process this GO :0060021 and palate development and biological process this GO :0060170 and ciliary membrane and cellular component this GO :0060173 and limb development and biological process this GO :0060271 and cilium morphogenesis and biological process, this GO :0001103 : RNA polymerase II repressing transcription factor binding, this GO :0001103 : RNA polymerase II repressing transcription factor binding and also this GO :0005515 : protein binding, this GO :0005515 : protein binding, Bardet-Biedl syndrome 7 |
| Identity: |
18758 |
| Gene: |
BBS7 |
More about : BBS7 |
| Long gene name: |
Bardet-Biedl syndrome 7 |
| Synonyms: |
FLJ10715 BBS2L1 |
| Locus: |
4q27 |
| Discovery year: |
2003-02-05 |
| GenBank acession: |
AF521644 |
| Entrez gene record: |
55212 |
| Classification: |
Bardet-Biedl syndrome associated BBSome |
| Havana BLAST/BLAT: |
OTTHUMG00000133076 |
| Locus Specific Databases: |
Mutations of the Bardet-Biedl Syndrome Type 7 Gene (BBS2L1) |